Hamilton Thorne (CVE:HTL) Stock Jumps 4.3% – What’s Next?
by Sarita Garza · The Markets DailyHamilton Thorne Ltd. (CVE:HTL – Get Free Report)’s share price traded up 4.3% during trading on Tuesday. The stock traded as high as C$1.45 and last traded at C$1.45. Approximately 25,700 shares traded hands during mid-day trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.
Hamilton Thorne Stock Performance
The company has a market cap of C$149.69 million, a PE ratio of 58.94 and a beta of 0.54. The company has a current ratio of 2.04, a quick ratio of 2.25 and a debt-to-equity ratio of 43.24. The firm’s 50-day simple moving average is C$1.45 and its two-hundred day simple moving average is C$1.45.
About Hamilton Thorne
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Further Reading
- Five stocks we like better than Hamilton Thorne
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?